CD86 and lung adenocarcinoma: We found that the expression of CD28, CD80, andCD86 was markedly reduced, suggesting that PSMB6 may decrease their expression to reduce the binding between CD80/CD86 and CD28, ultimately leading to immune evasion in lung adenocarcinoma cells.